A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis
Article in Biomedicine & Pharmacotherapy (October 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (October 2023)
Article in Gene (November 2022)